STOCK TITAN

Vor Biopharma: Venrock group reports 9.9% stake

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Vor Biopharma Inc. (VOR) shares were reported as beneficially owned by a group of seven reporting persons, with an aggregate position of 6,443,619 shares as of September 30, 2026, or 9.9% of the class. Each reporting person reported shared voting and dispositive power over that same aggregate. The reporting persons are Venrock Healthcare Capital Partners III, L.P.; VHCP Co-Investment Holdings III, LLC; Venrock Healthcare Capital Partners EG, L.P.; VHCP Management III, LLC; VHCP Management EG, LLC; Nimish Shah; and Bong Y. Koh.

The position comprises common stock and pre-funded warrants immediately exercisable for common shares, held through VHCP III, VHCP Co-Investment III and VHCP EG. Nimish Shah and Bong Y. Koh are voting members of VHCP Management III and VHCP Management EG.

Aggregate beneficial ownership 6,443,619 shares Reported by each reporting person as of September 30, 2026
Percent of class 9.9% Reported ownership as of September 30, 2026
Common shares held by VHCP III 642,031 shares As of September 30, 2026
Shares underlying VHCP III pre-funded warrants Up to 792,983 common shares Warrants immediately exercisable
Common shares held by VHCP Co-Investment III 64,214 shares As of September 30, 2026
Shares underlying VHCP Co-Investment III pre-funded warrants Up to 79,264 common shares Warrants immediately exercisable
Common shares held by VHCP EG 2,335,474 shares As of September 30, 2026
Shares underlying VHCP EG pre-funded warrants Up to 2,529,653 common shares Warrants immediately exercisable
Pre-Funded Warrants financial
"Pre-Funded Warrants immediately exercisable for up to 792,983 shares of common stock"
Pre-funded warrants are financial instruments that give investors the right to purchase a company's stock at a set price, but with most or all of the purchase price paid upfront. They function like a coupon or gift card for stock, allowing investors to buy shares later at a fixed price, which can be beneficial if they want to avoid future price increases. This makes them important for investors seeking flexibility and certainty in their investment plans.
beneficially owned regulatory
"shares beneficially owned by each reporting person"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
shared voting power regulatory
"Shared Voting Power 6,443,619.00"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
shared dispositive power regulatory
"Shared Dispositive Power 6,443,619.00"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many VOR shares did the reporting persons beneficially own?

The reporting persons each reported beneficial ownership of 6,443,619 shares, equal to 9.9% of the class as of September 30, 2026. The percentage was based on 61,429,555 common shares outstanding as of that date, giving effect to pre-funded warrants.

What common shares and warrants made up the reported VOR position?

VHCP III held 642,031 common shares and pre-funded warrants immediately exercisable for up to 792,983 common shares; VHCP Co-Investment III held 64,214 common shares and warrants for up to 79,264 shares; and VHCP EG held 2,335,474 common shares and warrants for up to 2,529,653 shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





929033207

(CUSIP Number)
09/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Venrock Healthcare Capital Partners III, L.P.
Signature:/s/ Sherman G. Souther
Name/Title:By VHCP Management III, LLC, its General Partner, By Sherman G. Souther, Authorized Signatory
Date:11/16/2026
VHCP Co-Investment Holdings III, LLC
Signature:/s/ Sherman G. Souther
Name/Title:By VHCP Management III, LLC, its Manager, By Sherman G. Souther, Authorized Signatory
Date:11/16/2026
Venrock Healthcare Capital Partners EG, L.P.
Signature:/s/ Sherman G. Souther
Name/Title:By VHCP Management EG, LLC, its General Partner, By Sherman G. Souther, Authorized Signatory
Date:11/16/2026
VHCP Management III, LLC
Signature:/s/ Sherman G. Souther
Name/Title:By Sherman G. Souther, Authorized Signatory
Date:11/16/2026
VHCP Management EG, LLC
Signature:/s/ Sherman G. Souther
Name/Title:By Sherman G. Souther, Authorized Signatory
Date:11/16/2026
Nimish Shah
Signature:/s/ Sherman G. Souther
Name/Title:By Sherman G. Souther, Attorney-in-fact
Date:11/16/2026
Bong Y. Koh
Signature:/s/ Sherman G. Souther
Name/Title:By Sherman G. Souther, Attorney-in-fact
Date:11/16/2026
Exhibit Information

Exhibit 24.1 Power of Attorney for Nimish P. Shah (incorporated by reference to Exhibit 24.1 to the Reporting Persons' Schedule 13G filed with the SEC on September 25, 2025). Exhibit 24.2 Power of Attorney for Bong Y. Koh (incorporated by reference to Exhibit 24.2 to the Reporting Persons' Schedule 13G filed with the SEC on September 25, 2025). Exhibit 99.1 Joint Filing Agreement (incorporated by reference to Exhibit 99.1 to the Reporting Persons' Schedule 13G filed with the SEC on September 25, 2025).

Keep reading